|
| Status |
Public on Oct 20, 2020 |
| Title |
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
34232320 |
| |
| Submission date |
Oct 19, 2020 |
| Last update date |
Oct 28, 2021 |
| Contact name |
Obada Taleb Alhalabi |
| E-mail(s) |
obadath@hotmail.com
|
| Organization name |
German Cancer Research Center DKFZ
|
| Department |
Brain Tumor Translational Targets
|
| Lab |
Violaine Goidts
|
| Street address |
Im Neuenheimer Feld 580 - TP3
|
| City |
Heidelberg |
| ZIP/Postal code |
69120 |
| Country |
Germany |
| |
|
| Platforms (2) |
| GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
| GPL21185 |
Agilent-072363 SurePrint G3 Human GE v3 8x60K Microarray 039494 [Probe Name Version] |
|
| Samples (20)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE159605 |
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma [Agilent] |
| GSE159607 |
A novel patient stratification strategy to enhance the therapeutic efficacy of dasatinib in glioblastoma [Illumina] |
|
| Relations |
| BioProject |
PRJNA669855 |
Less...
More...